Skip to main content
EJNMMI Reports
Fig. 5 | European Journal of Hybrid Imaging

Fig. 5

From: Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients

Fig. 5

Box plot showing the distribution of activity relative differences (between activity to be administered following personalized dosimetry and activity actually administered following classical standard approach) in 2 subgroups of group A (complete or partial response evaluated at 3 months following mRECIST target criteria with perfused tumor dose above 205 Gy versus stable or progression disease with perfused tumor dose under 205 Gy)

Back to article page